pulmonology News
-
Symberix CEO Presents at Translational Microbiome Conference
Dr. Ward Peterson delivered a presentation entitled “When Good Bugs Do Bad Things: Targeting the Microbiome to Make Better Human Genome-Targeted Drugs” at the annual Translational Microbiome Conference on May 14, 2015 in Boston. The Conference focused on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make ...
-
AlveoliX and EpiEndo Receive Eurostar Grant
The Swiss National Science Foundation SNSF and the Swiss Innovation Agency Innosuisse have granted a BRIDGE Discovery project to the Laboratory of Microbiology at the University of Neuchâtel (LAMUN) in cooperation with the Centre Hospitalier Universitaire Vaudois (CHUV), the Swiss Institute of Bioinformatics (SIB), and two innovative Swiss startups AlveoliX AG and SiMPLInext SA. The aim of ...
By AlveoliX AG
-
Noah Medical Presents Data, Showcases the Galaxy System at CHEST Annual Meeting
Medical robotics innovator Noah Medical provided physicians attending the American College of Chest Physicians 2022 meeting with a preview of study data documenting its high tool in lesion rate. This data subset and demonstrations of the Galaxy System were met with excellent reviews from the interventional pulmonology community. The Galaxy System is designed to provide a fully integrated ...
By Noah Medical
-
Monarch Platform Featured on Cover of Oncology Issues
The Monarch Platform was featured on the cover of the March-April 2019 issue of Oncology Issues. The journal, which is the official journal of the Association of Community Cancer Centers, was created for multidisciplinary oncology teams to provide information on a range of topics in cancer care. In the March-April issue of the journal, the Monarch Platform was featured in an article titled ...
-
Diffusion Pharmaceuticals Announces Clearance of IND Application for TSC by FDA’s Pulmonology, Allergy, and Critical Care Division
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (Diffusion or the Company), an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced that the Company has obtained clearance of its Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration’s ...
By CervoMed
-
Noah Medical to Showcase the Galaxy System at AABIP Annual Meeting
Medical robotics innovator Noah Medical today revealed that the second public demonstration of its groundbreaking Galaxy System will take place from August 11th - 13th at the American Association for Bronchology and Interventional Pulmonology (AABIP) annual meeting in Nashville, TN. The Galaxy System is the only fully integrated solution for navigated bronchoscopy, designed to dramatically ...
By Noah Medical
-
Quebec University in Laval, Canada. This is the first tricuspid valve replacement in Canada
The Institut universitaire de cardiologie et de pneumologie de Québec–Université Laval (the Institute) recently successfully performed a first case of percutaneous tricuspid replacement. So far, only 10 patients worldwide have undergone this type of percutaneous replacement. The procedure was performed by Dr. François Dagenais, cardiac surgeon and head of the Cardiac ...
-
Mauna Kea Technologies Receives FDA 510(k) Clearance of Cellvizio® with a Fluorescent Dye, Fluorescein, as Drug Device Combination
The Cellvizio®100 series system with all its different Confocal Miniprobes™ is now cleared for use with the fluorescein dye to image blood flow in the microvasculature and capillaries Mauna Kea Technologies today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Cellvizio® 100 series and all associated Confocal Miniprobes™ for ...
-
Thermo Fisher Scientific Introduces Oncomine Clinical Research Grant Program to Support Oncology and Reproductive Health Studies
Thermo Fisher Scientific today introduced the Oncomine Clinical Research Grant Program to support clinical research projects in oncology and reproductive health. The program aims to provide support for high-quality molecular profiling studies focused on the generation of data that may improve clinical outcomes for patients in the future. As part of an initial pilot focused on oncology, the ...
-
Mauna Kea Technologies Participates in Dutch Molecular Imaging Consortium that was Awarded €5.4 Million
MEDPHOT consortium aims to develop light-based molecular imaging solution for pulmonary diseases Mauna Kea Technologies today announced it is part of a molecular imaging consortium that was awarded €5.4 million by the Perspective Program of the Netherlands Organization for Scientific Research (NWO). Molecular imaging provides insight into molecular and cellular processes in the body, and ...
-
TeraRecon Announces DocPanel Signs Contract for Intuition Titanium, Reaffirming its Cardiothoracic Imaging Service Commitment
TeraRecon, a ConcertAI company and a leader in advanced medical visualization using AI to improve patient care, today announced U.S.-based DocPanel, the world’s first radiology marketplace offering access to over 500 fellowship trained radiologists available for radiological reads, second opinions, and educational consults, has signed a contract for TeraRecon’s advanced visualization ...
-
PharmAbcine Signs MoU with FutureChem to Explore Possibilities of Developing Novel Radiopharmaceuticals
PharmAbcine Signs MoU with FutureChem to Explore Possibilities of Developing Novel Radiopharmaceuticals PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that it signed an MoU (Memorandum of Understanding) with FutureChem Co., Ltd. (“FutureChem”) (KOSDAQ: 220100ks), a leading ...
-
MedTech Innovator Announces Finalists for $500K 8th Annual Industry Accelerator Competition
MedTech Innovator, the largest accelerator of medical devices in the world, today announced the finalists for MedTech Innovator’s eighth annual competition: Cellvie, Circadia Health, Lief Therapeutics, Moray Medical, and Rhaeos. Virtual attendees of The MedTech Conference, the largest gathering of medtech industry leaders in North America, powered by AdvaMed, will vote online to choose the ...
-
CONVERT Clinical Trial Data Presented at ERS Demonstrates Early Success of AeriSeal System in Patients with Advanced COPD/Emphysema
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announces the presentation of interim results from the CONVERT Study at the 2022 European Respiratory Society (ERS) International Conference. Data on the first 40 patients in the study demonstrated that treatment with the AeriSeal System successfully converted the ...
-
Medimprove – A New Private Clinic For Lung Revalidation With FRI
To address the need for better chronic respiratory care, Prof De Backer, emeritus Professor Pulmonology at the University of Antwerp and Chairman of The board of FLUIDDA NV, has opened a private clinic in Belgium near the Fluidda headquarters in Kontich, Belgium. The clinic uses a multidisciplinary approach for chronic respiratory failure. Care at this private clinic can involve exercise ...
By Fluidda
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you